2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine

C52H99N3O12 — CID 162987557

IUPAC2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine
SMILESCCCCCC[C@@H]1C(=O)O[C@@H]([C@H](C)[C@H](O)CCCN=C(N)N)[C@@H](C)C=C(C)CCCC[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H](O)CC=C(C)[C@@H](O)CCC[C@H](O)CCC[C@H](O)CC[C@@H](C)[C@@H]1O
InChIInChI=1S/C52H99N3O12/c1-7-8-9-10-21-46-49(65)36(4)25-26-40(57)19-13-18-39(56)20-14-22-47(63)35(3)24-27-42(59)31-44(61)33-45(62)32-43(60)30-41(58)17-12-11-16-34(2)29-37(5)50(67-51(46)66)38(6)48(64)23-15-28-55-52(53)54/h24,29,36-50,56-65H,7-23,25-28,30-33H2,1-6H3,(H4,53,54,55)/t36-,37+,38-,39-,40+,41+,42+,43+,44-,45+,46+,47+,48-,49+,50-/m1/s1
InChIKeyOKSCRTAGZOIPHI-MOEJFYIZSA-N
MW958.37 g/mol
LogP5.59
Rot. Bonds11

About 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine

2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine (PubChem CID 162987557) has the molecular formula C52H99N3O12 and a molecular weight of 958.37 g/mol. Its IUPAC name is 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine.

Molecular Properties

Compound Name2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine
PubChem CID162987557
Molecular FormulaC52H99N3O12
Molecular Weight958.37 g/mol
Exact Mass957.72
IUPAC Name2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine
SMILESCCCCCC[C@@H]1C(=O)O[C@@H]([C@H](C)[C@H](O)CCCN=C(N)N)[C@@H](C)C=C(C)CCCC[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H](O)CC=C(C)[C@@H](O)CCC[C@H](O)CCC[C@H](O)CC[C@@H](C)[C@@H]1O
InChIInChI=1S/C52H99N3O12/c1-7-8-9-10-21-46-49(65)36(4)25-26-40(57)19-13-18-39(56)20-14-22-47(63)35(3)24-27-42(59)31-44(61)33-45(62)32-43(60)30-41(58)17-12-11-16-34(2)29-37(5)50(67-51(46)66)38(6)48(64)23-15-28-55-52(53)54/h24,29,36-50,56-65H,7-23,25-28,30-33H2,1-6H3,(H4,53,54,55)/t36-,37+,38-,39-,40+,41+,42+,43+,44-,45+,46+,47+,48-,49+,50-/m1/s1
InChIKeyOKSCRTAGZOIPHI-MOEJFYIZSA-N
XLogP5.59
TPSA293.00 Ų
H-Bond Donors12
H-Bond Acceptors13
Rotatable Bonds11
Heavy Atoms67
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 500958.37
LogP ≤ 55.59
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine?
The IUPAC name of 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine (CID 162987557) is 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine.
What is the SMILES notation for 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine?
The canonical SMILES for 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine is CCCCCC[C@@H]1C(=O)O[C@@H]([C@H](C)[C@H](O)CCCN=C(N)N)[C@@H](C)C=C(C)CCCC[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H](O)CC=C(C)[C@@H](O)CCC[C@H](O)CCC[C@H](O)CC[C@@H](C)[C@@H]1O.
What is the InChIKey of 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine?
The InChIKey is OKSCRTAGZOIPHI-MOEJFYIZSA-N. The full InChI is InChI=1S/C52H99N3O12/c1-7-8-9-10-21-46-49(65)36(4)25-26-40(57)19-13-18-39(56)20-14-22-47(63)35(3)24-27-42(59)31-44(61)33-45(62)32-43(60)30-41(58)17-12-11-16-34(2)29-37(5)50(67-51(46)66)38(6)48(64)23-15-28-55-52(53)54/h24,29,36-50,56-65H,7-23,25-28,30-33H2,1-6H3,(H4,53,54,55)/t36-,37+,38-,39-,40+,41+,42+,43+,44-,45+,46+,47+,48-,49+,50-/m1/s1.
What are the key properties of 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine?
2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine has a molecular weight of 958.37 g/mol, XLogP of 5.59, 11 rotatable bonds, 12 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(4R,5R)-5-[(2R,3S,10S,12S,14S,16R,18S,22S,26R,30S,33R,34S,35S)-35-hexyl-10,12,14,16,18,22,26,30,34-nonahydroxy-3,5,21,33-tetramethyl-36-oxo-1-oxacyclohexatriaconta-4,20-dien-2-yl]-4-hydroxyhexyl]guanidine is sourced from PubChem (CID 162987557), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).